Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

78 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Dose-dense adjuvant chemotherapy in node-positive breast cancer: docetaxel followed by epirubicin/cyclophosphamide (T/EC), or the reverse sequence (EC/T), every 2 weeks, versus docetaxel, epirubicin and cyclophosphamide (TEC) every 3 weeks. AERO B03 randomized phase II study.
Piedbois P, Serin D, Priou F, Laplaige P, Greget S, Angellier E, Teissier E, Berdah JF, Fabbro M, Valenza B, Herait P, Jehl V, Buyse M. Piedbois P, et al. Among authors: teissier e. Ann Oncol. 2007 Jan;18(1):52-57. doi: 10.1093/annonc/mdl355. Epub 2006 Oct 17. Ann Oncol. 2007. PMID: 17047001 Free article. Clinical Trial.
Ten-year survival results of a randomized trial of irradiation of internal mammary nodes after mastectomy.
Hennequin C, Bossard N, Servagi-Vernat S, Maingon P, Dubois JB, Datchary J, Carrie C, Roullet B, Suchaud JP, Teissier E, Lucardi A, Gerard JP, Belot A, Iwaz J, Ecochard R, Romestaing P. Hennequin C, et al. Among authors: teissier e. Int J Radiat Oncol Biol Phys. 2013 Aug 1;86(5):860-6. doi: 10.1016/j.ijrobp.2013.03.021. Epub 2013 May 9. Int J Radiat Oncol Biol Phys. 2013. PMID: 23664327 Clinical Trial.
A phase III adjuvant randomised trial of 6 cycles of 5-fluorouracil-epirubicine-cyclophosphamide (FEC100) versus 4 FEC 100 followed by 4 Taxol (FEC-T) in node positive breast cancer patients (Trial B2000).
Delbaldo C, Serin D, Mousseau M, Greget S, Audhuy B, Priou F, Berdah JF, Teissier E, Laplaige P, Zelek L, Quinaux E, Buyse M, Piedbois P; Association Européenne de Recherche en Oncologie (AERO). Delbaldo C, et al. Among authors: teissier e. Eur J Cancer. 2014 Jan;50(1):23-30. doi: 10.1016/j.ejca.2013.09.023. Epub 2013 Oct 29. Eur J Cancer. 2014. PMID: 24183460 Clinical Trial.
[Management and clinical outcome in patients over 80 years with rectal cancer treated between 2006 and 2008 in Southern France (PACA region)].
Moureau-Zabotto L, Gal J, Resbeut M, Mineur L, Teissier É, Hébuterne X, Muyldermans P, Francois É, Chamorey E, Gérard JP. Moureau-Zabotto L, et al. Among authors: teissier e. Cancer Radiother. 2015 Dec;19(8):725-32. doi: 10.1016/j.canrad.2015.05.029. Epub 2015 Nov 11. Cancer Radiother. 2015. PMID: 26548601 French.
Use of the folinic acid/5-fluorouracil/irinotecan (FOLFIRI 1) regimen in elderly patients as a first-line treatment for metastatic colorectal cancer: a Phase II study.
François E, Berdah JF, Chamorey E, Lesbats G, Teissier E, Codoul JF, Badetti JL, Hébert C, Mari V. François E, et al. Among authors: teissier e. Cancer Chemother Pharmacol. 2008 Nov;62(6):931-6. doi: 10.1007/s00280-008-0681-2. Epub 2008 Feb 14. Cancer Chemother Pharmacol. 2008. PMID: 18273618 Clinical Trial.
78 results